Cystic fibrosis drug reduces hospital visits and offers patients hope – at a cost New report finds that Trikafta patients’ admissions to hospital fell by an average of 65 per cent over one year – but at a list price of over $300,000, the drug is not yet considered cost effective

Cystic fibrosis drug reduces hospital visits and offers patients hope – at a cost